Xtant Medical Holdings Stock Performance
| XTNT Stock | USD 0.48 0.03 5.88% |
On a scale of 0 to 100, Xtant Medical holds a performance score of 9. The firm maintains a market beta of 1.45, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Xtant Medical will likely underperform. Please check Xtant Medical's total risk alpha and the relationship between the downside variance and period momentum indicator , to make a quick decision on whether Xtant Medical's historical returns will revert.
Risk-Adjusted Performance
OK
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Xtant Medical Holdings are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unsteady basic indicators, Xtant Medical unveiled solid returns over the last few months and may actually be approaching a breakup point. ...more
Last Split Factor 1:12 | Dividend Date 2018-02-14 | Last Split Date 2018-02-14 |
1 | Disposition of 105442 shares by Sean Browne of Xtant Medical at 1.08 subject to Rule 16b-3 | 12/19/2024 |
2 | Disposition of 56333 shares by Kevin Brandt of Xtant Medical at 0.6 subject to Rule 16b-3 | 12/27/2024 |
3 | Three Value Stocks Estimated Below Intrinsic Worth For January 2025 | 01/14/2025 |
4 | 3 Stocks That May Be Trading Up To 40.9 percent Below Estimated Intrinsic Value | 01/15/2025 |
5 | Xtant Medical Stock Price Passes Above 200-Day Moving Average - Heres Why - MarketBeat | 02/07/2025 |
6 | NanoVibronix, Inc. Announces Acquisition of ENvue Medical Holdings, Corp. | 02/14/2025 |
7 | Adagio Medical to Participate at the TD Cowens 45th Annual Health Care Conference | 02/18/2025 |
8 | Asian Value Stocks Trading Below Estimated Worth In March 2025 | 03/05/2025 |
9 | Xtant Medical Holdings Inc Reports Q4 EPS of 0. ... | 03/06/2025 |
10 | Q4 2024 Xtant Medical Holdings Inc Earnings Call Transcript | 03/07/2025 |
| Begin Period Cash Flow | 5.9 M |
Xtant |
Xtant Medical Relative Risk vs. Return Landscape
If you would invest 35.00 in Xtant Medical Holdings on December 16, 2024 and sell it today you would earn a total of 13.00 from holding Xtant Medical Holdings or generate 37.14% return on investment over 90 days. Xtant Medical Holdings is currently generating 0.684% in daily expected returns and assumes 5.8502% risk (volatility on return distribution) over the 90 days horizon. In different words, 52% of stocks are less volatile than Xtant, and 87% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Xtant Medical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Xtant Medical's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Xtant Medical Holdings, and traders can use it to determine the average amount a Xtant Medical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1169
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | XTNT | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 5.85 actual daily | 52 52% of assets are less volatile |
Expected Return
| 0.68 actual daily | 13 87% of assets have higher returns |
Risk-Adjusted Return
| 0.12 actual daily | 9 91% of assets perform better |
Based on monthly moving average Xtant Medical is performing at about 9% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Xtant Medical by adding it to a well-diversified portfolio.
Xtant Medical Fundamentals Growth
Xtant Stock prices reflect investors' perceptions of the future prospects and financial health of Xtant Medical, and Xtant Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Xtant Stock performance.
| Return On Equity | -0.35 | ||||
| Return On Asset | -0.081 | ||||
| Profit Margin | (0.14) % | ||||
| Operating Margin | (0.06) % | ||||
| Current Valuation | 99.87 M | ||||
| Shares Outstanding | 139.07 M | ||||
| Price To Earning | (0.41) X | ||||
| Price To Book | 1.65 X | ||||
| Price To Sales | 0.57 X | ||||
| Revenue | 117.27 M | ||||
| Gross Profit | 68.22 M | ||||
| EBITDA | (12.07 M) | ||||
| Net Income | (16.45 M) | ||||
| Cash And Equivalents | 16.5 M | ||||
| Cash Per Share | 0.19 X | ||||
| Total Debt | 12.94 M | ||||
| Debt To Equity | 0.60 % | ||||
| Current Ratio | 3.57 X | ||||
| Book Value Per Share | 0.31 X | ||||
| Cash Flow From Operations | (11.9 M) | ||||
| Earnings Per Share | (0.12) X | ||||
| Market Capitalization | 66.75 M | ||||
| Total Asset | 93.84 M | ||||
| Retained Earnings | (259.46 M) | ||||
| Working Capital | 38.53 M | ||||
| Current Asset | 45.04 M | ||||
| Current Liabilities | 21.47 M | ||||
About Xtant Medical Performance
Assessing Xtant Medical's fundamental ratios provides investors with valuable insights into Xtant Medical's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Xtant Medical is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 287.48 | 378.37 | |
| Return On Tangible Assets | (0.21) | (0.22) | |
| Return On Capital Employed | (0.19) | (0.19) | |
| Return On Assets | (0.18) | (0.18) | |
| Return On Equity | (0.38) | (0.36) |
Things to note about Xtant Medical Holdings performance evaluation
Checking the ongoing alerts about Xtant Medical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Xtant Medical Holdings help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Xtant Medical is way too risky over 90 days horizon | |
| Xtant Medical has some characteristics of a very speculative penny stock | |
| Xtant Medical appears to be risky and price may revert if volatility continues | |
| The company reported the previous year's revenue of 117.27 M. Net Loss for the year was (16.45 M) with profit before overhead, payroll, taxes, and interest of 68.22 M. | |
| Xtant Medical Holdings currently holds about 16.5 M in cash with (11.9 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.19. | |
| Xtant Medical has a frail financial position based on the latest SEC disclosures | |
| Roughly 70.0% of the company outstanding shares are owned by institutional investors | |
| Latest headline from gurufocus.com: Q4 2024 Xtant Medical Holdings Inc Earnings Call Transcript |
- Analyzing Xtant Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Xtant Medical's stock is overvalued or undervalued compared to its peers.
- Examining Xtant Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Xtant Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Xtant Medical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Xtant Medical's stock. These opinions can provide insight into Xtant Medical's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Xtant Stock Analysis
When running Xtant Medical's price analysis, check to measure Xtant Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Xtant Medical is operating at the current time. Most of Xtant Medical's value examination focuses on studying past and present price action to predict the probability of Xtant Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Xtant Medical's price. Additionally, you may evaluate how the addition of Xtant Medical to your portfolios can decrease your overall portfolio volatility.